John Delgado, MD, Faafm
About John Delgado, MD, Faafm
John Delgado, MD, FAAM, serves as the Chief Medical Officer at Velocity Clinical Research, Inc. He has a background in medicine and biomedical innovation, having co-founded Eluciderm Inc. and led various clinical research projects.
Work at Velocity Clinical Research
John Delgado serves as the Chief Medical Officer at Velocity Clinical Research, Inc., a position he has held since 2021. In this role, he oversees clinical operations and ensures the integrity of clinical research processes. His leadership contributes to the advancement of clinical trials and the development of innovative treatment options. Delgado's experience in both medical practice and research enhances the company's capabilities in conducting high-quality clinical studies.
Education and Expertise
John Delgado earned his Doctor of Medicine (MD) degree from the David Geffen School of Medicine at UCLA. He also studied Biology at Stanford University, where he gained foundational knowledge in the life sciences. His educational background equips him with a strong understanding of both clinical and biomedical fields, allowing him to bridge the gap between medical practice and research.
Background
John Delgado has a diverse background that includes both medical practice and biomedical innovation. He co-founded Eluciderm Inc., a company dedicated to advancing biomedical innovations. His experience as a Principal Investigator allows him to lead clinical research projects effectively, contributing to the development of new therapies and medical advancements.
Achievements
As Chief Medical Officer at Velocity Clinical Research, John Delgado has played a significant role in leading clinical research projects. His work as a Principal Investigator highlights his commitment to advancing medical knowledge and improving patient outcomes. His involvement in co-founding Eluciderm Inc. demonstrates his dedication to fostering innovation in the biomedical field.